Reuters logo
BRIEF- IBA to divest PharmaLogic PET Services of Montreal company assets
March 17, 2014 / 6:10 AM / 4 years ago

BRIEF- IBA to divest PharmaLogic PET Services of Montreal company assets

BRUSSELS, March 17 (Reuters) - Ion Beam Applications SA : * Says IBA closes agreement to divest PharmaLogic pet services of Montreal company assets * About 85 percent of price has been paid to PharmaLogic at closing and rest will be released after a two year period * Says payments will then be distributed as dividends to PharmaLogic’s shareholders, including IBA * Says expects a net total cash inflow in dividend from this sale of about EUR 7.7 million * Deal will have no impact on 2013 accounts, but should positively impact IBA’s 2014 net results by approximately EUR 3.5 million

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below